Pharma news
Americas
In a decision with implications for biotechnology licensing and pharmaceutical manufacturing, the Ninth Circuit has rejected a ‘sweeping’ royalty trigger from a lower court. 26 February 2026
Americas
The Danish company is contending with fierce competition, a clinical trial setback and a UK boost to its main rival, while making new moves to enforce its weight-loss-drug IP. 25 February 2026
Careers
The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters. 24 February 2026
Careers
The new hire has “deep experience in high-stakes International Trade Commission proceedings”, whose specialisms include medical devices, pharma and genomics. 20 February 2026
Pharma
Courts on both sides of the Atlantic recorded a flurry of settlements this week, as Astellas, GSK, and Alexion drew a line under long-running disputes with generic rivals. 11 February 2026
Americas
Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product. 10 February 2026
Americas
A Delhi High Court ruling signals more bad news for the Danish pharma giant in the same week that it lost nearly $50 billion in value. 6 February 2026
Asia
The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market. 5 February 2026
Careers
The new hire, who has clients in pharma and medical devices and diagnostics, will lead the Dublin office's IP & Technology practice. 4 February 2026
Americas
Nominations are open for the Life Sciences Patent Network's 2026 awards in Boston, including six new categories and winners selected by leading industry experts. 3 February 2026